Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 2536 in Advanced Metastatic Hormone-refractory Prostate Cancer
NCT00706498Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2006
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BI-2536 in prostate cancer (PCa), sponsored by Boehringer Ingelheim. Started Sep 2006; status: completed.
02
Drugs
BI-2536
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00706498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00706498.